Clinical Trial Update: BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness [Phase 2]

View source ↗

Summary

Phase 2 trial of BEN-2001 in Parkinson's disease patients with excessive daytime sleepiness has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Parkinson Disease

Drugs mentioned

• BEN-2001

Snippet

Sponsor: BenevolentAI Bio | Conditions: Excessive Daytime Sleepiness, Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24